This Week in Pediatric Oncology
The podcast exploring hot topics and exciting advances in childhood cancer. "This Week in Pediatric Oncology" (TWIPO) is produced by Solving Kids' Cancer, nonprofits located in New York and London, dedicated to improving research and supporting families because Every Kid Deserves to Grow Up.
CLICK TO SUBSCRIBE TO TWIPO ON:
This Week in Pediatric Oncology - Episode #46
ANR Recap: Interview With Dr. Sue Cohn
March 30, 2015 — Host Dr. Nilay Shah (Nationwide Children’s Hospital) interviewed Susan L. Cohn, MD, a Professor of Pediatrics, Dean of Clinical Research at the University of Chicago at the ANR meeting in Cologne, Germany last year. Dr. Cohn is a highly respected expert in pediatric cancers and blood diseases. She is a leading authority on neuroblastoma and actively researching several aspects of neuroblastoma. Her research has received generous support from the National Institutes of Health/National Cancer Institute and the National Institute of Neurological Disorders and Stroke.
This Week in Pediatric Oncology - Episode #45
Immunotherapy Vaccine for High-Grade Gliomas
November 18, 2014 — In the most recent episode of This Week in Pediatric Oncology, co-hosts Dr. Nilay Shah (Nationwide Children’s Hospital), Dr. Timothy Cripe (Nationwide Children’s Hospital), and Dr. Lionel Chow (Cincinnati Children’s) discuss the promising results of a study published in the July issue of Journal of Clinical Oncology among children with an aggressive brain tumor after receiving immunotherapy. To see a summary of the study, click here.
This Week in Pediatric Oncology - Episode #44
ANR Recap: Interview With Professor Michelle Haber & Professor Andrew Pearson
November 10, 2014 — Co-hosts Dr. Keri Streby and Dr. Nilay Shah (Nationwide Children’s Hospital), caught up with Professor Michelle Haber (Executive Director at Children’s Cancer Institute in Australia and Professor Andrew Pearson of the Cancer Research UK. In this 26-minute podcast, both researchers discuss the future of neuroblastoma, specifically looking at precision medicine, the role of gene sequencing, and the role of international collaboration to bring new therapies into the clinic.
This Week in Pediatric Oncology - Episode #43
Langerhans cell histiocytosis: Interview With Carl E. Allen
October 1, 2014 — Co-hosts Dr. Edwin Horwitz, Dr. Nilay Shah, and Dr. Robyn Dennis from Nationwide Children's Hospital, interview Dr. Carl E. Allen, (Texas Children’s Cancer and Hematology Centers) about his research in a rare pediatric blood disorder known as Langerhans cell histiocytosis (LCH). Dr. Allen is Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology - Baylor College of Medicine, and the Co-Director of the Histiocytosis and Lymphoma Programs at Texas Children's Cancer and Hematology Centers. His primary research is focused on the clinical and biological aspects of LCH.
This Week in Pediatric Oncology - Episode #42
ANR Meeting Recap: Interview With Frank Berthold
July 23, 2014 — This Week in Pediatric Oncology presents the third and final interview from the recent Advances in Neuroblastoma Research meeting, which was held in Cologne, Germany, in May. Co-hosts Dr. Nilay Shah (Nationwide Children’s Hospital) and Dr. Keri Stretby (Nationwide Children’s Hospital) talk with Frank Berthold, ANR2014 Local Chairman, to discuss meeting highlights in the short, 18-minute interview.
This Week in Pediatric Oncology - Episode #41
ANR Meeting Recap: Advances in Understanding MIBG Therapy
July 15, 2014 — Co-hosts Dr. Nilay Shah and Dr. Keri Stretby (Nationwide Children’s Hospital) discuss MIBG therapy in treating children with high-risk neuroblastoma with Dr. Kate Matthay (UCSF Benioff Children's Hospital) and Dr. Gregory Yanik (C.S. Mott Children’s Hospital at the University of Michigan). In this 45-minute interview, both Drs. Matthay and Yanik, who have conducted extensive research in MIBG throughout their long careers, share their perspectives on what’s going on in the field now and opportunities to improve the therapy in the future.
This Week in Pediatric Oncology - Episode #40
ANR Meeting Recap: Advances in Understanding MYCN
July 10, 2014 — Co-hosts Dr. Nilay Shah and Dr. Keri Stretby (Nationwide Children’s Hospital) caught up with two pediatric oncologists who’ve made significant advances in neuroblastoma research. In this 25-minute interview, Dr. Robert Seeger (Children's Hospital of Los Angeles) and Dr. Garrett Brodeur (Children’s Hospital of Philadelphia) discuss how the discovery of the MYCN gene 30 years ago has helped scientists better understand neuroblastoma and impacted treatment options.
This Week in Pediatric Oncology - Episode #39
Declining Childhood Cancer Mortality & CAR123 T-cells
July 10, 2014 — Co-hosts Dr. Timothy Cripe, Dr. Robyn Dennis from Nationwide Children's Hospital, Dr. Andy Kolb (A.I. Dupont) and Dr. Lionel Chow (Cincinnati Children's) discuss two recent papers on the declining mortality rate in childhood and adolescent cancers and a pre-clinical study using CAR123 T-cells.
This Week in Pediatric Oncology - Episode #38
An Interview with John Goldberg, MD, on Phase I Clinical Trials
March 11, 2014 — Dr. Golberg talks about the challenges of phase I pediatric cancer clinical trials with hosts Dr. Tim Cripe (Nationwide Children's Hospital), Dr. Robyn Dennis (Nationwide Children's Hospital), and Mark Ranalli, MD (Nationwide Children's Hospital). Dr. Goldberg is an Assistant Professor of Pediatrics and the Director of the Pediatric Oncology Early Phase Clinical Trials Program at The Sylvester Comprehensive Cancer Center, the University of Miami.
This Week in Pediatric Oncology - Episode #37
An Interview with Patrick Brown, MD, on Infant Leukemia
February 26, 2014 — Dr. Brown talks about treating infant leukemia and the challenges of doing clinical trials in this patient population with hosts Dr. Tim Cripe (Nationwide Children's Hospital) and Dr. Robyn Dennis (Nationwide Children's Hospital). Dr. Brown is the Director, Pediatric Leukemia and Lymphoma Program and Associate Professor of Oncology and Assistant Professor of Pediatrics at The Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins School of Medicine.
This Week in Pediatric Oncology - Episode #36
An Interview With Kathleen Neville, MD, on Pediatric Drug Development
January 27, 2014 — Dr. Kathleen Neville talks about the challenges of drug development in pediatric cancer with host Dr. Tim Cripe (Nationwide Children's Hospital). Kathleen Neville is the Director of Experimental Therapeutics in the pediatric cancer program at Children's Mercy Hospital in Kansas City. She is an Associate Professor of Pediatrics in the division of pediatric clinical pharmacology, medical toxicology, and hematology-oncology at the University of Missouri-Kansas City School of Medicine.
This Week in Pediatric Oncology - Episode #35
An Interview with Robert Johnson, PhD
December 2, 2013 — Dr. Johnson speaks with host Dr. Tim Cripe and co-hosts Dr. Robyn Dennis (Nationwide Children's Hospital and Dr. Lionel Chow (Cincinnati Children's) about the third most common type of brain tumor in children, ependymomas. Robert A. Johnson, PhD, is a principal investigator at The Research Institute at Nationwide Children’s Hospital and an Assistant Professor of Pediatrics at The Ohio State University College of Medicine.
This Week in Pediatric Oncology - Episode #34
An Interview with Dr. Nancy Ratner
November 14, 2013 — Dr. Ratner speaks with host Dr. Tim Cripe (Nationwide Children's Hospital) and co-host Dr. Robyn Dennis (Nationwide Children's Hospital). Dr. Ratner is interested in understanding mechanisms of peripheral nerve tumor (neurofibroma) formation in Neurofibromatosis type 1 (NF1), a common inherited disorder in which children are predisposed to cancer of the nervous system, to learning problems, bone disorders, and other cancers. She identified EGFR as a potential therapeutic target in NF1 peripheral nerve tumorigenesis and has developed cell culture and mouse models of NF1 nerve tumorigenesis. Her laboratory has also used analysis of gene expression to identify critical genes in neurofibroma and their malignant derivatives, MPNST.
This Week in Pediatric Oncology - Episode #33
A Discussion with Gavin Lindberg on Effective Advocacy
October 31, 2013 — Mr. Lindberg speaks with host Dr. Tim Cripe and co-host Dr. Robyn Dennis (Nationwide Children’s Hospital), about his work to increase funding for childhood cancer research. Mr. Lindberg is the President and Co-Founder of The Evan’s Victory Against Neuroblastoma (EVAN) Foundation, which was established in memory of his only child Evan Lindberg. Evan bravely battled neuroblastoma for four years before passing away at the age of 7 in 2010. The Foundation funds research aimed at fostering new therapies for children with neuroblastoma and sponsors patient-wellness programs for childhood cancer patients enduring long and difficult stays in the hospital.
This Week in Pediatric Oncology - Episode #32
Ethics in Childhood Cancer Clinical Trials with Dr. Eric Kodish
October 18, 2013 — Eric Kodish, MD, is a featured guest on the recent episode of This Week in Pediatric Oncology. In this episode, Dr. Kodish speaks with host Dr. Tim Cripe (Nationwide Children’s Hospital), and co-host Dr. Andy Kolb (AI DuPont), about informed consent and ethics surrounding childhood cancer clinical trials.